Outcomes of the ACT III Study: Rindopepimut (CDX-110) Therapy for Glioblastoma.

Article Details

Citation

Copy to clipboard

Zussman BM, Engh JA

Outcomes of the ACT III Study: Rindopepimut (CDX-110) Therapy for Glioblastoma.

Neurosurgery. 2015 Jun;76(6):N17. doi: 10.1227/01.neu.0000465855.63458.0c.

PubMed ID

25985004 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drugs

Rindopepimut